A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia.
Yoshiya TanakaPublished in: Inflammation and regeneration (2023)
Thus, the development of molecular targeted drugs with elucidated pathological mechanisms may aid in controlling Covid-19 infection.